Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets.
about
Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic ratsDiabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?N-Acetylated Proline-Glycine-Proline Accelerates Cutaneous Wound Healing and Neovascularization by Human Endothelial Progenitor CellsGrain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses.Additive regulation of adiponectin expression by the mediterranean diet olive oil components oleic Acid and hydroxytyrosol in human adipocytes.Consequences of a Maternal High-Fat Diet and Late Gestation Diabetes on the Developing Rat Lung.Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells.SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery.The cardiovascular effects of insulin.AGEs Decreased SIRT3 Expression and SIRT3 Activation Protected AGEs-Induced EPCs' Dysfunction and Strengthened Anti-oxidant Capacity.The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing.The Role of Stem Cells in Wound Angiogenesis.Endothelial Permeability, Ldl Deposition, and Cardiovascular Risk Factors - A Review.Diabetes, cardiovascular disease and the microcirculation.
P2860
Q27300198-39B6202E-AF5E-4F67-BD41-46D20055D01DQ28082426-2A19FC48-2DB0-490D-A6AC-6FC060F673ACQ30839749-37F714FC-BC8F-4337-92E5-5BF21F286706Q34361728-AC9695D7-426F-45AA-804C-B89F9D248123Q35647737-F2CF22CA-E043-4731-B790-D2339C62559FQ36102740-C03CB80F-885E-4BF2-AD7E-43D3F3256E83Q36112416-77D39F31-C8A3-4B84-ACEE-6D0FC58F0432Q36237217-85851BEC-3E75-49BF-AA75-BEF9B761CCD7Q38217755-F7C983E7-1B63-43C3-BE9D-AFD92546E815Q39055132-33CD6EA4-554C-4B16-AD45-075DFA38A3A2Q42565183-B4C4D2AC-E7FD-422B-9B10-B38F85C30A10Q42926963-88C2C4D0-E72E-48B5-AF0E-7E1775827990Q46059179-30FA7908-7948-42F7-8A50-51B5164C7892Q54986438-ED3BBBF3-AD9C-467C-A3D1-C514B371B870
P2860
Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cellular and molecular mechani ...... nisms and therapeutic targets.
@en
Cellular and molecular mechani ...... nisms and therapeutic targets.
@nl
type
label
Cellular and molecular mechani ...... nisms and therapeutic targets.
@en
Cellular and molecular mechani ...... nisms and therapeutic targets.
@nl
prefLabel
Cellular and molecular mechani ...... nisms and therapeutic targets.
@en
Cellular and molecular mechani ...... nisms and therapeutic targets.
@nl
P1476
Cellular and molecular mechani ...... nisms and therapeutic targets.
@en
P2093
Raffaele De Caterina
Rosalinda Madonna
P356
10.1016/J.VPH.2011.03.007
P577
2011-03-29T00:00:00Z